The Effect of Children's Laughter Video on Oncology Patient

NCT ID: NCT07051616

Last Updated: 2025-07-04

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 36 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-09-15
• Study Completion Date: 2025-05-30

Brief Summary

This study was conducted to investigate the effect of video playback of children's laughter on anxiety, nausea, vomiting and fatigue levels of patients during chemotherapy

Detailed Description

Nausea and vomiting, anxiety and fatigue due to chemotherapy can be prevented or reduced with effective nursing interventions and care. Laughter therapy is an intervention that has been used in the symptom management of individuals with cancer in recent years. Studies focusing on humor and laughter have generally been conducted among cancer patients. Humor and laughter have been shown to have both physiological, psychological and sociological benefits for patients in general. When the studies on laughter yoga are examined, it is seen that the results of laughter therapy applied to individuals are examined. It has also been reported in the literature that laughter has a contagious effect, often occurring in groups of people. There is no study in the literature on the effect of children's laughter on adults. This study will reveal the effectiveness of infant and child laughter in patients receiving chemotherapy. It is thought that this study will constitute an important data source for experimental studies to be conducted.

Conditions

Anxiety; Chemotherapy Effect; Laughter; Fatigue; Nausea; Vomiting

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: SINGLE

Study Groups

Child laughter video group

Patients in this group were made to watch the laughter video prepared by the researchers at the end of the 1st and 2nd hour after the start of chemotherapy.

Group Type: EXPERIMENTAL

Child laughter video

Intervention Type: BEHAVIORAL

1 hour after the chemotherapy treatment was started, the video monitor was placed at a height where the patient could see comfortably while lying down and the video, which was checked and prepared beforehand, was turned on full screen. The appropriate volume was adjusted and the patient was allowed to watch the video for 10 minutes without any other intervention. The video was then stopped and the etagere was removed from in front of the patient. Chemotherapy was continued. At the 2nd hour of chemotherapy, the disinfected etagere and computer were placed in a position where the patient could see them comfortably and the 2nd video was started and the patient was allowed to watch the video for 10 minutes.

Control Group

Participants in the control group were not subjected to any intervention other than routine practice during chemotherapy.

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Child laughter video

1 hour after the chemotherapy treatment was started, the video monitor was placed at a height where the patient could see comfortably while lying down and the video, which was checked and prepared beforehand, was turned on full screen. The appropriate volume was adjusted and the patient was allowed to watch the video for 10 minutes without any other intervention. The video was then stopped and the etagere was removed from in front of the patient. Chemotherapy was continued. At the 2nd hour of chemotherapy, the disinfected etagere and computer were placed in a position where the patient could see them comfortably and the 2nd video was started and the patient was allowed to watch the video for 10 minutes.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Diagnosed with lymphoma (preferred to have the same type of cancer)
• Receiving the R - Chop cycle protocol as chemotherapy (This cycle was preferred because of the nausea and vomiting experienced in this protocol and the duration of the treatment is 4-5 hours) (Cleveland Clinic 2025).
• Inpatient hospitalization,
• Be over 18 years of age,
• Conscious, oriented and cooperative

Exclusion Criteria

• Don't take a different cure than R - Chop,
• Visual and hearing and cognitive impairment,
• Do not have a problem that creates a communication barrier,
• Having any psychiatric illness such as depression, euphoria and taking psychiatric medication
• Refusal to participate in the study
• Other non-pharmacological methods

• Minimum Eligible Age: 32 Years
• Maximum Eligible Age: 81 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Selcuk University

OTHER

Sponsor Role: lead

Responsible Party

Sibel Küçükoğlu

Prof

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Sibel Kucukoglu, Prof

Role: PRINCIPAL_INVESTIGATOR

Selcuk University

Locations

Sibel Küçükoğlu

Selçuklu, Akademi Mahallesi, Turkey (Türkiye)

Countries

Turkey (Türkiye)

Other Identifiers

2025/25

Identifier Type: -

Identifier Source: org_study_id